SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
BEIER DAVID W

(Last) (First) (Middle)
ONE AMGEN CENTER DRIVE

(Street)
THOUSAND OAKS CA 91320-1799

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/11/2008
3. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP Global Govt & Corp Affairs
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 25,000(1) D
Common Stock 15,824 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
ISO (Right to Buy) 03/15/2008(2) 03/15/2011 Common Stock 3,362 59.48 D
ISO (Right to Buy) 12/17/2004 12/17/2010 Common Stock 6,436 62.15 D
ISO (Right to Buy) 04/26/2011 04/26/2014 Common Stock 1,598 62.55 D
ISO (Right to Buy) 04/03/2010 04/03/2013 Common Stock 1,391 71.88 D
NQSO (Right to Buy) 03/15/2006(3) 03/15/2012 Common Stock 17,500 58.61 D
NQSO (Right to Buy) 03/15/2005(4) 03/15/2011 Common Stock 6,336 59.48 D
NQSO (Right to Buy) 12/17/2004(5) 12/17/2010 Common Stock 40,732 62.15 D
NQSO (Right to Buy) 04/26/2008(6) 04/26/2014 Common Stock 23,402 62.55 D
NQSO (Right to Buy) 04/03/2007(7) 04/03/2013 Common Stock 23,609 71.88 D
Explanation of Responses:
1. The Restricted Stock Units (RSUs) were granted under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs will fully vest on July 31, 2010. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the reporting person.
2. This option is exercisable in two equal annual installments of 1,681 shares each commencing March 15, 2008.
3. This option is exercisable in four equal annual installments of 4,375 shares each commencing March 15, 2006.
4. This option is exercisable in five annual installments as follows: 3,168 shares on March 15, 2005; 3,168 shares on March 15, 2006; 3,168 shares on March 15, 2007; 1,487 shares on March 15, 2008; and 1,487 shares on March 15, 2009.
5. This option was exercisable in four equal annual installments commencing December 17, 2004 and is now fully vested.
6. This option is exercisable in four annual installments as follows: 6,250 shares on April 26, 2008; 6,250 shares on April 26, 2009; 6,250 shares on April 26, 2010; and 4,652 shares on April 26, 2011.
7. This option is exercisable in four annual installments as follows: 6,250 shares on April 3, 2007; 6,250 shares on April 3, 2008; 6,250 shares on April 3, 2009; and 4,859 shares on April 3, 2010.
/s/ David W. Beier 03/18/2008
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
rrd178814_201904.html
                                                                    Exhibit 24.1
                               POWER OF ATTORNEY

        Know all men by these presents, that the undersigned hereby constitutes
and appoints each of N. Cris Prince, Andrea A. Robinson and Mark A. Schlossberg,
signing singly, the undersigned's true and lawful attorney-in-fact to execute
for and on behalf of the undersigned Forms 3, 4 and 5 in accordance with Section
16(a) of the Securities Exchange Act of 1934, as amended, and the rules
thereunder, as may be required as a result of the undersigned's position as an
officer and/or director of Amgen Inc. (the "Company").

        The undersigned hereby grants to each such attorney-in-fact full power
and authority to execute such Forms 3, 4 and 5 as fully to all intents and
purposes as the undersigned might or could do if personally present, with full
power of substitution or revocation, hereby ratifying and confirming all that
such attorney-in-fact, or such attorney-in-fact's substitute or substitutes,
shall lawfully do or cause to be done by virtue of this power of attorney and
the rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934, as amended.

        This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 17th day of March, 2008.

                                        /s/ David W. Beier
                                        ---------------------------------------
                                        Name:  David W. Beier